DMARDs for RA Improve Vascular Inflammation and CV Risk
Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular inflammation and cardiovascular risk.
United States Women College Hospital National Institute Of Arthritis Medscape Medical Rheumatic Diseases Medscape Medical News
Source: medscape.com